- Report
- November 2024
- 188 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- March 2025
- 50 Pages
Global
From €2531EUR$2,650USD£2,116GBP
- Report
- February 2024
- 123 Pages
Global
From €3500EUR$3,926USD£3,029GBP
Febantel is a broad-spectrum anthelmintic used in veterinary medicine to treat parasitic worms in animals. It is a member of the benzimidazole family of drugs, which are used to treat a variety of parasitic infections. Febantel is used to treat roundworms, hookworms, whipworms, and tapeworms in dogs, cats, horses, and other animals. It is also used to treat gastrointestinal parasites in livestock, such as sheep, goats, and cattle. Febantel is available in a variety of formulations, including tablets, suspensions, and injectables.
The Febantel market is a growing segment of the animal pharmaceuticals industry. It is driven by the increasing prevalence of parasitic infections in animals, as well as the need for effective treatments. The market is expected to continue to grow in the coming years, as new products are developed and new markets are explored.
Some companies in the Febantel market include Merck Animal Health, Bayer Animal Health, Elanco Animal Health, Zoetis, and Virbac. Show Less Read more